Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial

Brown, Jennifer R, Hamadani, Mehdi, Hayslip, John, Janssens, Ann, Wagner-Johnston, Nina, Ottmann, Oliver, Arnason, Jon, Tilly, Hervé, Millenson, Michael, Offner, Fritz, Gabrail, Nashat Y, Ganguly, Siddhartha, Ailawadh, Sikander, Kasar, Siddha, Kater, Arnon P, Doorduijn, Jeanette K, Gao, Lei, Lager, Joanne J, Wu, Bin, Egile, Coumaran and Kersten, Marie José 2018. Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial. Lancet Haematology 5 (4) , e170-e180. 10.1016/S2352-3026(18)30030-9

[img]
Preview
PDF - Accepted Post-Print Version
Download (821kB) | Preview
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Elsevier: Lancet
ISSN: 2352-3026
Date of First Compliant Deposit: 28 April 2018
Date of Acceptance: 14 March 2018
Last Modified: 14 Mar 2019 02:30
URI: http://orca.cf.ac.uk/id/eprint/111064

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics